| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.3 | 2e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-09 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.25 | 1e-08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.29 | 2e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.27 | 3e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |